
Infection Control
Description
Global Infection Control Market to Reach US$83.4 Billion by 2030
The global market for Infection Control estimated at US$56.3 Billion in the year 2024, is expected to reach US$83.4 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Protective Barriers, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$34.8 Billion by the end of the analysis period. Growth in the Sterilization Products & Services segment is estimated at 7.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$15.3 Billion While China is Forecast to Grow at 8.0% CAGR
The Infection Control market in the U.S. is estimated at US$15.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$12.9 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.4% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.
strong>Global Infection Control Market - Key Trends & Drivers Summarized
What Defines the Scope and Importance of Infection Control Today?
Infection control is a critical discipline within healthcare that aims to prevent or stop the spread of infections in healthcare facilities and communities. This field encompasses various practices, processes, and procedures used to minimize the risk of infection. It involves the use of disinfection methods, sterilization procedures, and sanitation practices to protect patients and healthcare workers alike. Infection control is essential not only in hospitals but also in other settings such as clinics, nursing homes, and at home, especially when caring for the elderly or those with weakened immune systems. The significance of infection control has been underscored by recent global health crises, where the lack of proper practices led to widespread outbreaks, highlighting the need for stringent and effective infection control measures.
How Have Pandemics Reinforced the Necessity for Robust Infection Control Measures?
The COVID-19 pandemic has dramatically transformed the landscape of infection control, bringing unprecedented attention and resources to this field. Healthcare facilities worldwide have revised and updated their infection control protocols to handle the surge in patients while preventing the spread of the virus within and beyond their walls. This situation has accelerated innovation in infection control technologies, such as UV-C disinfection, HEPA filters, and advanced personal protective equipment (PPE). Moreover, it has led to increased governmental and institutional investments in training healthcare workers in the best practices for infection prevention and control, which is critical in managing not only the current pandemic but also future outbreaks.
Which Technological Innovations Are Revolutionizing Infection Control?
Technology plays a pivotal role in advancing infection control measures. The development of new diagnostic tools has enabled faster identification of pathogens, which is crucial for effective infection control. Advanced sterilization technology, such as low-temperature plasma sterilization, offers more efficient and safer alternatives to traditional methods, which often involved toxic chemicals or high heat. Robotics and automation have also been introduced in some healthcare settings to decontaminate rooms and equipment more thoroughly and consistently than manual cleaning. Furthermore, information technology has facilitated better tracking and data analysis to monitor infection rates and outcomes, significantly enhancing infection control programs` effectiveness.
What Are the Major Drivers of Growth in the Infection Control Market?
The growth in the infection control market is driven by several factors, including increased awareness of healthcare-associated infections (HAIs), technological advancements in sterilization and disinfection products, and global health crises such as the COVID-19 pandemic. There is a growing demand for effective infection control solutions across various healthcare settings, driven by the need to improve patient safety and meet stringent regulatory standards. Technological innovations have led to the development of more effective and efficient infection control products, which are being rapidly adopted by healthcare facilities worldwide. Additionally, shifts in consumer behavior, particularly the increased emphasis on sanitation and hygiene practices observed in both healthcare workers and the general public, are further propelling the market growth.
SCOPE OF STUDY:The report analyzes the Infection Control market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Products & Services (Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products, Other Products & Services); End-Use (Hospitals & Clinics, Pharma & Medical Device Companies, Other End-Uses)
Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.
Select Competitors (Total 145 Featured) -
- 3M Company
- AstraZeneca PLC
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- bioMerieux SA
- AliMed, Inc.
- Baumer SA
- Ansell Ltd.
- Allegion PLC
- Alfred Becht GmbH
- Belimed AG
- A-dec Inc.
- Advanced Sterilization Products
- Ahlstrom-Munksjo
- ABC Dentistry & Orthodontics
We`re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Infection Control – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- Global Market Analysis and Prospects
- Product and End-use Segments
- Regional Market Analysis
- Market Growth Restraining Factors
- Recent Market Activity
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Sterilization Equipment Market Witnesses Rapid Growth
- Major Players in the Global Sterilization Equipment Market
- Low-Temperature Sterilization Gains Ground
- Leading Players in the Low-Temperature Sterilization Market
- Emergence of Outsourcing Trend Bodes Well for Sterilization Services
- E-beam Sterilization of Medical Devices Registers Rapid Growth
- Endoscope Contamination – A Major Health Hazard Driving the Demand for Sterilization Equipment
- Increasing Need to Reduce Hospital-Acquired Infections Propel Market Demand
- Leading Nosocomial Infections in the US: Percentage Breakdown of Healthcare Cost by Infection Type
- Government Support to Ensure Infection Control in Clinical Settings to Boost Demand for Infection Control Products
- Increasing Prevalence of Chronic Disorders, Rise in Surgical Procedures and the Need to Prevent Transmission of Infections Fuels Market Growth
- Aging Population – A Key Growth Driver
- Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- Rising Demand for Medical Devices Augurs Well for the Market
- Surgical Drapes and Gowns: Indispensable for Safe Healthcare
- Surgical Gowns Market: Stable Growth Outlook
- High Demand for Disposable Drapes and Gowns
- Growth in Medical Device Reprocessing to Offer New Areas of Growth
- Improving Healthcare Expenditure to Bode Well for Market Growth
- Technological Advancements
- Sealive’s Biovector Sterilization Technology for more Effective Inactivation of Viruses and Microorganisms
- Introduction of Business-Friendly Policies and Guidelines Fuel Demand for Eco-Friendly Medical Sterilization Equipment
- Challenges and Future Prospects
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Protective Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 2: World Historic Review for Protective Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 3: World 15-Year Perspective for Protective Barriers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Sterilization Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 5: World Historic Review for Sterilization Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 6: World 15-Year Perspective for Sterilization Products & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Cleaning & Disinfection Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 8: World Historic Review for Cleaning & Disinfection Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 9: World 15-Year Perspective for Cleaning & Disinfection Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Endoscope Reprocessing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 11: World Historic Review for Endoscope Reprocessing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 12: World 15-Year Perspective for Endoscope Reprocessing Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Other Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 14: World Historic Review for Other Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 15: World 15-Year Perspective for Other Products & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 17: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 18: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 20: World Historic Review for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 21: World 15-Year Perspective for Pharma & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 25: World Infection Control Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 28: World 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- III. MARKET ANALYSIS
- UNITED STATES
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 29: USA Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 30: USA Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 31: USA 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 32: USA Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 34: USA 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- CANADA
- TABLE 35: Canada Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 36: Canada Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 37: Canada 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 38: Canada Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: Canada Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 40: Canada 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- JAPAN
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 41: Japan Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: Japan Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 43: Japan 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 44: Japan Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: Japan Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 46: Japan 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- CHINA
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 47: China Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: China Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 49: China 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 50: China Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: China Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 52: China 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- EUROPE
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 53: Europe Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Europe Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 55: Europe 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 56: Europe Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Europe Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 58: Europe 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- TABLE 59: Europe Recent Past, Current & Future Analysis for Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 60: Europe Historic Review for Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 61: Europe 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- FRANCE
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 62: France Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: France Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 64: France 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 65: France Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: France Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 67: France 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- GERMANY
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 68: Germany Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: Germany Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 70: Germany 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 71: Germany Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: Germany Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 73: Germany 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- ITALY
- TABLE 74: Italy Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: Italy Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 76: Italy 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 77: Italy Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: Italy Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 79: Italy 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- UNITED KINGDOM
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 80: UK Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: UK Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 82: UK 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 83: UK Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: UK Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 85: UK 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- SPAIN
- TABLE 86: Spain Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: Spain Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 88: Spain 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 89: Spain Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: Spain Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 91: Spain 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- RUSSIA
- TABLE 92: Russia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Russia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 94: Russia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 95: Russia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Russia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 97: Russia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF EUROPE
- TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Rest of Europe Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 100: Rest of Europe 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Rest of Europe Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 103: Rest of Europe 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- ASIA-PACIFIC
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Asia-Pacific Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 106: Asia-Pacific 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: Asia-Pacific Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 109: Asia-Pacific 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 111: Asia-Pacific Historic Review for Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 112: Asia-Pacific 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- AUSTRALIA
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 113: Australia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: Australia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 115: Australia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 116: Australia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: Australia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 118: Australia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- INDIA
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 119: India Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: India Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 121: India 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 122: India Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: India Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 124: India 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- SOUTH KOREA
- TABLE 125: South Korea Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: South Korea Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 127: South Korea 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 128: South Korea Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: South Korea Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 130: South Korea 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF ASIA-PACIFIC
- TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Rest of Asia-Pacific Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: Rest of Asia-Pacific Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- LATIN AMERICA
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 137: Latin America Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Latin America Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 139: Latin America 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 140: Latin America Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Latin America Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 142: Latin America 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- TABLE 143: Latin America Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 144: Latin America Historic Review for Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 145: Latin America 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- ARGENTINA
- TABLE 146: Argentina Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Argentina Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 148: Argentina 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 149: Argentina Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Argentina Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 151: Argentina 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- BRAZIL
- TABLE 152: Brazil Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 153: Brazil Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 154: Brazil 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 155: Brazil Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Brazil Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 157: Brazil 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- MEXICO
- TABLE 158: Mexico Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Mexico Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 160: Mexico 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 161: Mexico Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Mexico Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 163: Mexico 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF LATIN AMERICA
- TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: Rest of Latin America Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 166: Rest of Latin America 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: Rest of Latin America Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 169: Rest of Latin America 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- MIDDLE EAST
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 170: Middle East Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: Middle East Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 172: Middle East 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 173: Middle East Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: Middle East Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 175: Middle East 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- TABLE 176: Middle East Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 177: Middle East Historic Review for Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 178: Middle East 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- IRAN
- TABLE 179: Iran Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: Iran Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 181: Iran 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 182: Iran Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: Iran Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 184: Iran 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- ISRAEL
- TABLE 185: Israel Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: Israel Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 187: Israel 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 188: Israel Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: Israel Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 190: Israel 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- SAUDI ARABIA
- TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 192: Saudi Arabia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 193: Saudi Arabia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: Saudi Arabia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 196: Saudi Arabia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- UNITED ARAB EMIRATES
- TABLE 197: UAE Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 198: UAE Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 199: UAE 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 200: UAE Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 201: UAE Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 202: UAE 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF MIDDLE EAST
- TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Rest of Middle East Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 205: Rest of Middle East 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Rest of Middle East Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 208: Rest of Middle East 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- AFRICA
- Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 209: Africa Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: Africa Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 211: Africa 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
- TABLE 212: Africa Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 213: Africa Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 214: Africa 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
- IV. COMPETITION
Pricing
Currency Rates